Skip to content
2000
Volume 6, Issue 1
  • ISSN: 2213-235X
  • E-ISSN: 2213-2368

Abstract

Background: Agmatine, an endogenous amine, is cosidered a novel neuromodulator with neuroprotective properties. However, the mechanisms involved in these protective effects are poorly understood. Methods: Fourier Transform Infrared (FTIR) spectroscopy analysis detects biomolecular changes in disordered cells and tissues. In the present study, we employ FTIR spectroscopy to characterize the changes in rotenone-induced damage in neuronal-like differentiated SH-SY5Y neuroblastoma cells in the presence or absence of agmatine. Results: The analysis of the FTIR spectra evidences significant alterations in rotenone-treated cells that are reduced by the pre-incubation with agmatine (250 nM). In particular, rotenone-damaged cells demonstrate spectral alterations related to amide I, which correspond to an increase in β-sheet components, and decreases in the amide II absorption intensity, suggesting a loss of N-H bending and C-N stretching. These alterations were also evident by Fourier self-deconvolution analysis. Thus, rotenone induced increases in the levels of stretching vibration band related to the protein carboxyl group would account for a significant amount of misfolded proteins in the cell. Agmatine effectively reduces these effects of rotenone on protein structure. Conclusion: In conclusion, antioxidant and scavenging properties of agmatine reduce rotenoneproduced cellular damage at the level of protein structure. Our results, together with other previous observations, make agmatine a potential therapeutic agent in the treatment of Parkinson's disease.

Loading

Article metrics loading...

/content/journals/cmb/10.2174/2213235X04666161118144545
2018-04-01
2025-10-11
Loading full text...

Full text loading...

/content/journals/cmb/10.2174/2213235X04666161118144545
Loading

  • Article Type:
    Research Article
Keyword(s): FTIR; mitochondrial impairment; neuron; oxidative stress; scavenging; static magnetic fields
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test